Literature DB >> 18985995

Plasma appearance rate of intraperitoneal macromolecular tracer underestimates peritoneal lymph flow.

El Rasheid Zakaria1, Chester J Mays, Paul J Matheson, Ryan T Hurt, Richard N Garrison.   

Abstract

The magnitude of peritoneal lymph flow is an issue of great controversy in peritoneal dialysis (PD) research. Because no single lymphatic duct drains the entire peritoneal cavity, peritoneal lymph flow is indirectly measured as lymphatic removal of intraperitoneal macromolecular tracer. In rats, the peritoneal clearance (K) of such a tracer is 5 times the approximately 8 microL/min determined from the tracer appearance rate in blood (Cl). The fractional contribution of tissues bordering the peritoneal cavity to the overall Cl was determined to be diaphragm, 55%; viscera, 30%; and abdominal wall, 15%. The present study determines whether direct measurement of visceral peritoneal lymph flow matches the 30% (approximately 2.5 microL/min) contribution of the visceral peritoneal lymph flow as measured indirectly by the Cl method. The mesenteric lymph duct that exclusively drains lymph from the gut, liver, and mesentery was cannulated in 15 rats, and lymph flow from the duct was collected at hourly intervals up to 6 hours under near-normal physiologic conditions and under conditions of simulated PD. Changes in mesenteric lymph flow that resulted from a challenge with 3 mL intravenous saline were captured using real-time video. We observed no significant differences between the hourly lymph volumes collected over 6 hours in naïve animals (n = 5, p > 0.05). Under conditions of simulated PD with dialysis fluid in the peritoneal cavity, the mesenteric duct lymph flow averaged 8.67 +/- 1.41 microL/min (n = 10). That flow is similar to reported data on total peritoneal Cl in rats; and 4 times the 2.5 microL/min visceral peritoneal contribution to the total peritoneal Cl. The intravenous saline challenge significantly increased mesenteric lymph duct output to 30.9 +/- 1.6 microL/min (n = 5, p < 0.01) and reduced the lymph-to-plasma concentration ratio (L/P) by 43%. The reflection coefficient for total proteins (sigma(prot)) across the intestinal capillaries as calculated from the filtration rate-dependent L/P ratio when the transcapillary fluid escape rate and the mesenteric lymph flow were both high was more than 0.87. We concluded that (A) under near-normal physiologic conditions, the mesenteric lymph duct flow is steady, but quite low; (B) under conditions of simulated PD, the mesenteric lymph duct flow increases significantly from the physiologic norm; (C) mesenteric lymph duct flow is sensitive to the peritoneal fill volume; (D) during simulated PD, the fractional visceral peritoneal lymph flow measured indirectly from plasma appearance of intraperitoneal tracer underestimates the directly measured mesenteric duct lymph flow; and (E) the increased transcapillary fluid escape rate is rapidly buffered by augmentation of mesenteric lymph duct output.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18985995      PMCID: PMC2596618     

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  27 in total

1.  Effective lymphatic absorption rate is not a useful or accurate term to use in the physiology of peritoneal dialysis.

Authors:  Michael Flessner
Journal:  Perit Dial Int       Date:  2004 Jul-Aug       Impact factor: 1.756

2.  The effective lymphatic absorption rate is an accurate and useful concept in the physiology of peritoneal dialysis.

Authors:  Raymond T Krediet
Journal:  Perit Dial Int       Date:  2004 Jul-Aug       Impact factor: 1.756

3.  Bidirectional peritoneal transport of immunoglobulin in rats: compartmental kinetics.

Authors:  M F Flessner; R L Dedrick; J C Reynolds
Journal:  Am J Physiol       Date:  1992-02

4.  Lymphatic versus nonlymphatic fluid absorption from the peritoneal cavity as related to the peritoneal ultrafiltration capacity and sieving properties.

Authors:  B Rippe; E R Zakaria
Journal:  Blood Purif       Date:  1992       Impact factor: 2.614

5.  In vivo hydraulic conductivity of muscle: effects of hydrostatic pressure.

Authors:  J Lofthouse; M F Flessner
Journal:  Am J Physiol       Date:  1997-12

6.  Transport of tracer albumin from peritoneum to plasma: role of diaphragmatic, visceral, and parietal lymphatics.

Authors:  E R Zakaria; O Simonsen; A Rippe; B Rippe
Journal:  Am J Physiol       Date:  1996-05

7.  Estimation of lymphatic absorption and intraperitoneal volume during hypertonic peritoneal dialysis.

Authors:  R Mactier; R Khanna; Z Twardowski; K D Nolph
Journal:  ASAIO Trans       Date:  1988 Jan-Mar

8.  Lymphatic drainage of the peritoneal cavity in sheep.

Authors:  N J Abernethy; W Chin; J B Hay; H Rodela; D Oreopoulos; M G Johnston
Journal:  Am J Physiol       Date:  1991-03

9.  Clearance of tracer albumin from peritoneal cavity to plasma at low intraperitoneal volumes and hydrostatic pressures.

Authors:  Q Zhu; O Carlsson; B Rippe
Journal:  Perit Dial Int       Date:  1998 Sep-Oct       Impact factor: 1.756

10.  In vivo effects of hydrostatic pressure on interstitium of abdominal wall muscle.

Authors:  E R Zakaria; J Lofthouse; M F Flessner
Journal:  Am J Physiol       Date:  1999-02
View more
  3 in total

1.  Plasma appearance rate of intraperitoneal macromolecular tracer underestimates peritoneal lymph flow.

Authors:  El Rasheid Zakaria; Chester J Mays; Paul J Matheson; Ryan T Hurt; Richard N Garrison
Journal:  Adv Perit Dial       Date:  2008

Review 2.  Peritoneal changes in patients on long-term peritoneal dialysis.

Authors:  Raymond T Krediet; Dirk G Struijk
Journal:  Nat Rev Nephrol       Date:  2013-05-14       Impact factor: 28.314

3.  Measuring peritoneal absorption with the prolonged peritoneal equilibration test from 4 to 8 hours using various glucose concentrations.

Authors:  Josep Teixidó-Planas; Maria Isabel Troya-Saborido; Guillermo Pedreira-Robles; Milagros Del-Rio-Lafuente; Ramon Romero-Gonzalez; Josep Bonet-Sol
Journal:  Perit Dial Int       Date:  2014 Sep-Oct       Impact factor: 1.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.